FDA Device Recalls

Recalls /

#144451

Product

Oblique Posterior Atraumatic Lumbar (OPAL) System, Polymeric spinal fusion cage, non-sterile, OPAL Spacer 10 mm x 24 mm, 11 mm Height - Revolve Product Usage - The OPAL Spacer is indicated for use in patients with degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1 whose condition requires the use of interbody fusion combined with supplemental fixation. The interior of the OPAL Spacer should be packed with autogenous bone graft (i.e. autograft). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six months or non-operative treatment. The OPAL Spacer is intended to be used with Synthes supplemental fixation, e.g. TSLP, ATB, Antegra, Pangea, USS Including ClickX) and small stature USS.

FDA product code
MAXIntervertebral Fusion Device With Bone Graft, Lumbar
Device class
Class 2
Medical specialty
Orthopedic
510(k) numbers
K072791
Affected lot / code info
Lot # 9984134, Catalog ID 08.803.051, OPAL Spacer 10 mm x 24 mm, 11 mm Height - Revolve

Why it was recalled

The label on the outer packaging does not match the product inside and intended use of the device.

Root cause (FDA determination)

Labeling mix-ups

Action the firm took

DePuy Synthes sent an Urgent Notice letter dated February 18, 2016 to customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed to review inventory, immediately remove the affected lots from their stock and complete the attached Verification Section. For questions call 610-719-5450 or contact your DePuy Synthes Sales Consultant

Recalling firm

Firm
Synthes (USA) Products LLC
Address
1301 Goshen Pkwy, West Chester, Pennsylvania 19380-5986

Distribution

Distribution pattern
Distributed in the US: OH and ND

Timeline

Recall initiated
2016-02-18
Terminated
2016-11-08
Status

Source: openFDA Device Recall endpoint. Recall record ID #144451. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.